Sirona Biochem Corp. (SRBCF)
OTCMKTS · Delayed Price · Currency is USD
0.0213
0.00 (0.00%)
Sep 2, 2025, 8:00 PM EDT
Sirona Biochem Revenue
Sirona Biochem had revenue of 2.54K CAD in the quarter ending July 31, 2024, a decrease of -62.69%. This brings the company's revenue in the last twelve months to -16.36K, down -119.39% year-over-year. In the fiscal year ending October 31, 2023, Sirona Biochem had annual revenue of 34.78K, down -94.82%.
Revenue (ttm)
-16.36K CAD
Revenue Growth
-119.39%
P/S Ratio
-901.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.68M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2023 | 34.78K | -637.14K | -94.82% |
Oct 31, 2022 | 671.92K | 403.90K | 150.70% |
Oct 31, 2021 | 268.02K | 162.31K | 153.54% |
Oct 31, 2020 | 105.71K | -30.03K | -22.12% |
Oct 31, 2019 | 135.74K | -1.14M | -89.38% |
Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
Sirona Biochem News
- 4 weeks ago - Sirona Biochem Update to Shareholders on Financial Status and Operations - GlobeNewsWire
- 4 months ago - Sirona Biochem Announces Debenture Financing - GlobeNewsWire
- 4 months ago - Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH - GlobeNewsWire
- 8 months ago - Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report - GlobeNewsWire
- 10 months ago - Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology - GlobeNewsWire
- 1 year ago - SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout - GlobeNewsWire
- 1 year ago - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report - GlobeNewsWire
- 1 year ago - SIRONA BIOCHEM Corporate Update April 2024 - GlobeNewsWire